Robert Scala

Robert Scala currently serves as the VP of Business Operations and Launch Planning at Lexicon Pharmaceuticals, Inc. Since November 2021, Scala has held various leadership positions in the biopharmaceutical industry, including roles as VP of Commercial Operations & Launch Planning at BioXcel Therapeutics Inc., Chief Commercial Officer at Vaccinex, and VP of Business Planning and Commercial Operations at DBV Technologies. Scala's experience includes transforming Radius Health from a development-focused biotech into a fully operational commercial entity and building Eisai’s Neurology Commercial Development and Global Marketing Group. Scala's earlier career includes significant roles at Merck and Pfizer, with responsibilities spanning operations, strategic planning, and marketing. Scala holds a Bachelor's degree in Accounting & Finance from Seton Hall University.